what are Analysts report about MER Telemanagement Solutions Ltd.(NASDAQ:MTSL): Second Sight Medical Products, Inc.(NASDAQ:EYES)

0
5

Many analysts are providing their Estimated Earnings analysis for MER Telemanagement Solutions Ltd. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

The Relative Volume of the company is 4.94 and Average Volume (3 months) is 14.94 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is -5.6%.

While looking at the Stock’s Performance, MER Telemanagement Solutions Ltd. currently shows a Weekly Performance of 11.37%, where Monthly Performance is -4.4%, Quarterly performance is -8.41%, 6 Months performance is -11.04% and yearly performance percentage is 0%. Year to Date performance value (YTD perf) value is -4.85%. The Stock currently has a Weekly Volatility of 9.49% and Monthly Volatility of 7.19%.

Second Sight Medical Products, Inc. (EYES) will report its next earnings on Mar 25 AMC. The company reported the earnings of $-0.5/Share in the last quarter where the estimated EPS by analysts was $-0.49/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -2%.

Many analysts are providing their Estimated Earnings analysis for Second Sight Medical Products, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.47/share. These analysts have also projected a Low Estimate of $-0.54/share and a High Estimate of $-0.41/share.

These analysts also forecasted Growth Estimates for the Current Quarter for EYES to be 41.3%. They are projecting Next Quarter growth of 14.58%. For the next 5 years, Second Sight Medical Products, Inc. is expecting Growth of 20.06% per annum, whereas in the past 5 years the growth was 7.33% per annum.

Some buy side analysts are also providing their Analysis on Second Sight Medical Products, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 5.24 and Average Volume (3 months) is 375.69 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -121.5%. The Return on Equity (ROE) value stands at -188.5%. While it’s Return on Investment (ROI) value is -465.1%.

While looking at the Stock’s Performance, Second Sight Medical Products, Inc. currently shows a Weekly Performance of 14.26%, where Monthly Performance is -40.23%, Quarterly performance is -79.12%, 6 Months performance is -84.89% and yearly performance percentage is -81.67%. Year to Date performance value (YTD perf) value is -82.48%. The Stock currently has a Weekly Volatility of 9.27% and Monthly Volatility of 14.00%.

SHARE